Mesoblast Limited (NASDAQ: MESO) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT MESOBLAST LIMITED

Mesoblast Limited (NASDAQ: MESO)
Listen to this Section


$18.89
-1.5100 ( -1.02% ) 219.6K

Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.

Market Data


Open $18.89
Previous Close $20.40
Volume 219.6K
Market Cap $2.45B
Day Range $18.37 - $19.69
52 Week Range $1.75 - $22.00
Shares Outstanding 127.00M
Change % -1.02%
Net Change ▼ -1.5100
Insider Ownership N/A
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Biological Products (No Diagnostic Substances)
IPO Year 2010
Country Australia
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
sc Insider transactions 1 Apr 03, 2024
6-k Form 6-K 4 Mar 27, 2024
6-k Form 6-K 34 Mar 21, 2024
sc Insider transactions 1 Mar 20, 2024
6-k Form 6-K 4 Mar 15, 2024
6-k Form 6-K 5 Mar 12, 2024
6-k Form 6-K 47 Mar 01, 2024
6-k Form 6-K 99 Feb 29, 2024
6-k Form 6-K 5 Feb 21, 2024

Latest News


× Before browsing our site, please accept our cookies policy